Rob Kuhling came to ONSET Ventures in 1987 after experience in a variety of technology marketing, strategic development and management positions.
Rob was Director of Marketing at Sun Microsystems, where he spearheaded the company’s expansion into the design automation marketplace.
He also served as VP and Manager of General Electric-Calma’s $100 million electronic design automation business and was a team leader for Boston Consulting Group, where he oversaw the development of a range of corporate business strategies.
At ONSET Ventures, Rob invests in communications and networking companies and medical device companies. Rob serves on the boards of several public and private companies, and has led ONSET Ventures’ investments in companies like Aneurx, Clarify, Conceptus, Alteon, Packeteer, Embolic Protection, Endotex Interventional Systems, and Gadzoox Networks.
Rob’s current board memberships are Access Closure, Baronova, ClariPhy Communications and Uptake Medical.
Rob received his A.B. from Hamilton College and his MBA from Harvard Business School.
|Nov, 2015||BAROnova||$36.5M / Series D||ONSET Ventures|
|Aug, 2014||ClariPhy Communications||$19.74M / Venture||ONSET Ventures|
|Feb, 2013||BAROnova||$27.3M / Series C||ONSET Ventures|
|Oct, 2012||Access Closure||$998.1k / Venture||ONSET Ventures|
|Mar, 2012||Uptake Medical||$40.26M / Series C||ONSET Ventures|
|Jun, 2011||ClariPhy Communications||$14M / Series C||ONSET Ventures|
|Jul, 2010||Uptake Medical||$17.5M / Series B||ONSET Ventures|
|May, 2010||ClariPhy Communications||$24M / Series C||ONSET Ventures|
|Oct, 2008||BAROnova||$7.5M / Series B||ONSET Ventures|
|Jan, 2006||Invarium||$6M / Series B||ONSET Ventures|
|Jan, 2006||BAROnova||$6.5M / Series A||ONSET Ventures|